Nanorobots mediated drug delivery for brain cancer active targeting and controllable therapeutics
Source abstract
Abstract
Brain cancer pose significant life-threats by destructively invading normal brain tissues, causing dysneuria, disability and death, and its therapeutics is limited by underdosage and toxicity lying in conventional drug delivery that relied on passive delivery. The application of nanorobots-based drug delivery systems is an emerging field that holds great potential for brain cancer active targeting and controllable treatment. The ability of nanorobots to encapsulate, transport, and supply therapies directly to the lesion site through blood-brain barriers makes it possible to deliver drugs to hard-to-reach areas. In order to improve the efficiency of drug delivery and problems such as precision and sustained release, nanorobots are effectively realized by converting other forms of energy into propulsion and motion, which are considered as high-efficiency methods for drug delivery. In this article, we described recent advances in the treatment of brain cancer with nanorobots mainly from three aspects: firstly, the development history and characteristics of nanorobots are reviewed; secondly, recent research progress of nanorobots in brain cancer is comprehensively investigated, like the driving mode and mechanism of nanorobots are described; thirdly, the potential translation of nanorobotics for brain diseases is discussed and the challenges and opportunities for future research are outlined.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Micro and Nano Robotics · Molecular Communication and Nanonetworks · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS. Brain and other central nervous system tumor statistics, 2021. CA Cancer J Clin. 2021;71(5):381–406.10.3322/caac.21693 ↗
2. Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer. 2020;20(1):26–41.10.1038/s41568-019-0205-x ↗
3. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–51.10.1038/nbt.3330 ↗
4. Wang J, Dong Y, Ma P, Wang Y, Zhang F, Cai B, Chen P, Liu BF. Intelligent micro-/nanorobots for cancer theragnostic. Adv Mater. 2022;34(52):2201051.10.1002/adma.202201051 ↗
5. Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8(1):217.10.1038/s41392-023-01481-w ↗
6. Li X, Geng X, Chen Z, Yuan Z. Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy. Pharmacol Res. 2022;179:106218.10.1016/j.phrs.2022.106218 ↗
7. Kishore C, Bhadra P. Targeting brain cancer cells by nanorobot, a promising nanovehicle: new challenges and future perspectives. CNS Neurol Disord Drug Targets. 2021;20(6):531–9.10.2174/1871527320666210526154801 ↗
8. Yoo J, Tang S, Gao W. Micro-and nanorobots for biomedical applications in the brain. Nat Rev Bioeng. 2023. https://doi.org/10.1038/s44222-023-00038-4.10.1038/s44222-023-00038-4 ↗
9. Deng G, Peng X, Sun Z, Zheng W, Yu J, Du L, Chen H, Gong P, Zhang P, Cai L, Tang BZ. Natural-killer-cell-inspired nanorobots with aggregation-induced emission characteristics for near-infrared-ii fluorescence-guided glioma theranostics. ACS Nano. 2020;14(9):11452–62.10.1021/acsnano.0c03824 ↗
10. Zhang T-T, Li W, Meng G, Wang P, Liao W. Strategies for transporting nanoparticles across the blood–brain barrier. Biomater Sci. 2016;4(2):219–29.10.1039/C5BM00383K ↗
11. Jain K. Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother. 2007;7(4):363–72.10.1586/14737175.7.4.363 ↗
12. Li J, Esteban-Fernández B, de Ávila W, Gao LZ, Wang J. Micro/nanorobots for biomedicine: delivery, surgery, sensing, and detoxification. Sci Robot. 2017. https://doi.org/10.1126/scirobotics.aam6431.10.1126/scirobotics.aam6431 ↗
13. Kim K, Guo J, Xu X, Fan DL. Recent progress on man-made inorganic nanomachines. Small. 2015;11(33):4037–57.10.1002/smll.201500407 ↗
14. Nelson BJ, Kaliakatsos IK, Abbott JJ. Microrobots for minimally invasive medicine. Annu Rev Biomed Eng. 2010;12(1):55–85.10.1146/annurev-bioeng-010510-103409 ↗
15. Chen YY, Chen DX, Liang SZ, Dai YG, Bai X, Song B, Zhang DY, Chen HW, Feng L. Recent advances in field-controlled micro-nano manipulations and micro-nano robots. Adv Intell Syst. 2022. https://doi.org/10.1002/aisy.202100116.10.1002/aisy.202100116 ↗
16. Requicha AAG. Nanorobots, NEMS, and nanoassembly. Proc IEEE. 2003;91(11):1922–33.10.1109/JPROC.2003.818333 ↗
17. Li JH, Mayorga-Martinez CC, Ohl CD, Pumera M. Ultrasonically Propelled Micro- and Nanorobots. Adv Funct Mater. 2022. https://doi.org/10.1002/adfm.202102265.10.1002/adfm.202102265 ↗
18. Kong X, Gao P, Wang J, Fang Y, Hwang KC. Advances of medical nanorobots for future cancer treatments. J Hematol Oncol. 2023;16(1):74.10.1186/s13045-023-01463-z ↗
19. Freitas RA Jr. What is nanomedicine? Nanomed Nanotechnol Biol Med. 2005;1(1):2–9.10.1016/j.nano.2004.11.003 ↗
20. Feynman R. There’s plenty of room at the bottom. In Feynman and computation: CRC Press; 2018. p. 63–76.
21. Kwoh YS, Hou J, Jonckheere EA, Hayati S. A robot with improved absolute positioning accuracy for CT guided stereotactic brain surgery. IEEE Trans Biomed Eng. 1988;35(2):153–60.10.1109/10.1354 ↗
22. Marshall LH, Magoun HW, The Horsley–Clarke stereotaxic instrument: the beginning. Kopf Carrier October, 1990: 1–5.
23. Meeker DC, Maslen EH, Ritter RC, Creighton FM. Optimal realization of arbitrary forces in a magnetic stereotaxis system. IEEE Trans Magn. 1996;32(2):320–8.10.1109/20.486515 ↗
24. Tendick F, Sastry SS, Fearing RS, Cohn M. Applications of micromechatronics in minimally invasive surgery. IEEE/ASME Trans Mechatron. 1998;3(1):34–42.10.1109/3516.662866 ↗
25. Dolev S, Narayanan RP, Rosenblit M. Design of nanorobots for exposing cancer cells. Nanotechnology. 2019;30(31):315501.10.1088/1361-6528/ab1770 ↗
26. Cavalcanti A, Freitas RA Jr. Nanosystem design with dynamic collision detection for autonomous nanorobot motion control using neural networks. Comput Graph Geom J. 2003;5:33–49.
27. Martel S. Swimming microorganisms acting as nanorobots versus artificial nanorobotic agents: a perspective view from an historical retrospective on the future of medical nanorobotics in the largest known three-dimensional biomicrofluidic networks. Biomicrofluidics. 2016. https://doi.org/10.1063/1.4945734.10.1063/1.4945734 ↗
28. Purdy PD, Fujimoto T, Replogle RE, Giles BP, Fujimoto H, Miller SL. Percutaneous intraspinal navigation for access to the subarachnoid space: use of another natural conduit for neurosurgical procedures. Neurosurg Focus. 2005;19(1):1–5.10.3171/foc.2005.19.1.12 ↗
29. Rothemund PW. Folding DNA to create nanoscale shapes and patterns. Nature. 2006;440(7082):297–302.10.1038/nature04586 ↗
30. Felfoul O, Mohammadi M, Taherkhani S, de Lanauze D, Yong Zhong X, Loghin D, Essa S, Jancik S, Houle D, Lafleur M, Gaboury L, Tabrizian M, Kaou N, Atkin M, Vuong T, Batist G, Beauchemin N, Radzioch D, Martel S. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nat Nanotechnol. 2016;11(11):941–7. https://doi.org/10.1038/nnano.2016.137.10.1038/nnano.2016.137 ↗
31. Cavalcanti A, Shirinzadeh B, Fukuda T, Ikeda S. Nanorobot for brain aneurysm. Int J Robot Res. 2009;28(4):558–70.10.1177/0278364908097586 ↗
32. Deng Z, Li X, Zheng K, Yao W. A humanoid robot control system with SSVEP-based asynchronous brain-computer interface. Jiqiren. 2011;33(2):129–35.
33. Gao W, Kagan D, Pak OS, Clawson C, Campuzano S, Chuluun-Erdene E, Shipton E, Fullerton EE, Zhang L, Lauga E, Wang J. Cargo-towing fuel-free magnetic nanoswimmers for targeted drug delivery. Small. 2012;8(3):460–7.10.1002/smll.201101909 ↗
34. De Lanauze D, Felfoul O, Turcot J-P, Mohammadi M, Martel S. Three-dimensional remote aggregation and steering of magnetotactic bacteria microrobots for drug delivery applications. Int J Robot Res. 2014;33(3):359–74.10.1177/0278364913500543 ↗
35. Hamdi M, Ferreira A. Guidelines for the design of magnetic nanorobots to cross the blood–brain barrier. IEEE Trans Rob. 2013;30(1):81–92.10.1109/TRO.2013.2291616 ↗
36. Loscrì V, Natalizio E, Mannara V, Aloi G. In a novel communication technique for nanobots based on acoustic signals, bio-inspired models of network, information, and computing systems: 7th international ICST Conference, BIONETICS 2012, Lugano, Switzerland, December 10–11, 2012, Revised Selected Papers 7. Springer. 2014;2014:91–104.
37. Schwartz I, Meiner Z. Robotic-assisted gait training in neurological patients: who may benefit? Ann Biomed Eng. 2015;43(5):1260–9.10.1007/s10439-015-1283-x ↗
38. Amir Y, Abu-Horowitz A, Bachelet I. Folding and characterization of a bio-responsive robot from DNA origami. JoVE (Journal of Visualized Experiments). 2015;106:e51272.
39. Li J, Li X, Luo T, Wang R, Liu C, Chen S, Li D, Yue J, Cheng S-H, Sun D. Development of a magnetic microrobot for carrying and delivering targeted cells. Sci Robot. 2018;3(19):8829.10.1126/scirobotics.aat8829 ↗
40. Bradley CA. Drug delivery: DNA nanorobots - seek and destroy. Nat Rev Drug Discov. 2018;17(4):242.10.1038/nrd.2018.40 ↗
41. Chen J, Wang Y. Personalized dynamic transport of magnetic nanorobots inside the brain vasculature. Nanotechnology. 2020;31(49):495706.10.1088/1361-6528/abb392 ↗
42. Cao L, Li G, Xu Y, Zhang H, Shu X, Zhang D. A brain-actuated robotic arm system using non-invasive hybrid brain–computer interface and shared control strategy. J Neural Eng. 2021;18(4):046045.10.1088/1741-2552/abf8cb ↗
43. Chen B, Tan H, Ding M, Liu L, Wang S, Peng X, Tian H, Jiang J, Gao J, Huang W. Nanorobot-mediated synchronized neuron activation. ACS Nano. 2023;17(14):13826–39.10.1021/acsnano.3c03575 ↗
44. Wu J, Jiao N, Lin D, Li N, Ma T, Tung S, Cheng W, Wu A, Liu L. Dual-responsive nanorobot-based marsupial robotic system for intracranial cross-scale targeting drug delivery. Adv Mater. 2024;36(9):e2306876.10.1002/adma.202306876 ↗
45. Sireesha M, Jagadeesh Babu V, Kranthi Kiran AS, Ramakrishna S. A review on carbon nanotubes in biosensor devices and their applications in medicine. Nanocomposites. 2018;4(2):36–57.10.1080/20550324.2018.1478765 ↗
46. Conesa L, Costa U, Morales E, Edwards DJ, Cortes M, León D, Bernabeu M, Medina J. An observational report of intensive robotic and manual gait training in sub-acute stroke. J Neuroeng Rehabil. 2012;9:13.10.1186/1743-0003-9-13 ↗
47. Wu JF, Jiao ND, Lin DJ, Li N, Ma TY, Tung SV, Cheng W, Wu AH, Liu LQ. Dual-responsive nanorobot-based marsupial robotic system for intracranial cross-scale targeting drug delivery. Adv Mater. 2024. https://doi.org/10.1002/adma.202306876.10.1002/adma.202306876 ↗
48. Lee S, Kim JY, Kim J, Hoshiar AK, Park J, Lee S, Kim J, Pané S, Nelson BJ, Choi H. A needle-type microrobot for targeted drug delivery by affixing to a microtissue. Adv Healthcare Mater. 2020;9(7):1901697.10.1002/adhm.201901697 ↗
49. Servant A, Qiu F, Mazza M, Kostarelos K, Nelson BJ. Controlled in vivo swimming of a swarm of bacteria-like microrobotic flagella. Adv Mater. 2015;27(19):2981–8.10.1002/adma.201404444 ↗
50. Kim S, Qiu F, Kim S, Ghanbari A, Moon C, Zhang L, Nelson BJ, Choi H. Fabrication and characterization of magnetic microrobots for three-dimensional cell culture and targeted transportation. Adv Mater. 2013;25(41):5863–8.10.1002/adma.201301484 ↗
51. Kim S, Lee S, Lee J, Nelson BJ, Zhang L, Choi H. Fabrication and manipulation of ciliary microrobots with non-reciprocal magnetic actuation. Sci Rep. 2016;6(1):30713.10.1038/srep30713 ↗
52. Lee S, Kim S, Kim S, Kim J-Y, Moon C, Nelson BJ, Choi H. A Capsule-type microrobot with pick-and-drop motion for targeted drug and cell delivery. Adv Healthcare Mater. 2018. https://doi.org/10.1002/adhm.201700985.10.1002/adhm.201700985 ↗
53. Wrede P, Degtyaruk O, Kalva SK, Deán-Ben XL, Bozuyuk U, Aghakhani A, Akolpoglu B, Sitti M, Razansky D. Real-time 3D optoacoustic tracking of cell-sized magnetic microrobots circulating in the mouse brain vasculature. Sci Adv. 2022;8(19):eabm9132.10.1126/sciadv.abm9132 ↗
54. Soto F, Chrostowski R. Frontiers of medical micro/nanorobotics: in vivo applications and commercialization perspectives toward clinical uses. Front Bioeng Biotechnol. 2018;6:170.10.3389/fbioe.2018.00170 ↗
55. Feng Y, An M, Liu Y, Sarwar MT, Yang H. Advances in chemically powered micro/nanorobots for biological applications: a review. Adv Func Mater. 2023;33(1):2209883.10.1002/adfm.202209883 ↗
56. Wang J, Manesh KM. Motion control at the nanoscale. Small. 2010;6(3):338–45.10.1002/smll.200901746 ↗
57. Sundararajan S, Lammert PE, Zudans AW, Crespi VH, Sen A. Catalytic motors for transport of colloidal cargo. Nano Lett. 2008;8(5):1271–6.10.1021/nl072275j ↗
58. Qiao R, Fu C, Forgham H, Javed I, Huang X, Zhu J, Whittaker AK, Davis TP. Magnetic iron oxide nanoparticles for brain imaging and drug delivery. Adv Drug Deliv Rev. 2023;197:114822.10.1016/j.addr.2023.114822 ↗
59. Hu NN, Ding LJ, Liu YY, Wang KM, Zhang B, Yin RX, Zhou WJ, Bi ZM, Zhang WJ. Development of 3D-Printed magnetic micro-nanorobots for targeted therapeutics: the state of art. Adv Nanobiomed Res. 2023. https://doi.org/10.1002/anbr.202300018.10.1002/anbr.202300018 ↗
60. Guo Y, Jing D, Liu S, Yuan Q. Construction of intelligent moving micro/nanomotors and their applications in biosensing and disease treatment. Theranostics. 2023;13(9):2993–3020.10.7150/thno.81845 ↗
61. Wu Z, Chen Y, Mukasa D, Pak OS, Gao W. Medical micro/nanorobots in complex media. Chem Soc Rev. 2020;49(22):8088–112.10.1039/D0CS00309C ↗
62. Pulgar VM. Transcytosis to cross the blood brain barrier, new advancements and challenges. Front Neurosci. 2019;12:1019.10.3389/fnins.2018.01019 ↗
63. Gupta A, Soni S, Chauhan N, Khanuja M, Jain U. Nanobots-based advancement in targeted drug delivery and imaging: an update. J Control Release. 2022;349:97–108.10.1016/j.jconrel.2022.06.020 ↗
64. Freitas RA Jr. Microbivores: artificial mechanical phagocytes using digest and discharge protocol. J Evol Technol. 2005;14(1):54–106.
65. Kanaparthy R, Kanaparthy R. The changing face of dentistry: nanotechnology. Int J Nanomed. 2011. https://doi.org/10.2147/IJN.S24353.10.2147/IJN.S24353 ↗
66. Wu Z, Li T, Gao W, Xu T, Jurado-Sánchez B, Li J, Gao W, He Q, Zhang L, Wang J. Cell-membrane-coated synthetic nanomotors for effective biodetoxification. Adv Func Mater. 2015;25(25):3881–7.10.1002/adfm.201501050 ↗
67. Li J, Angsantikul P, Liu W, Esteban-Fernandez-de-Avila B, Chang X, Sandraz E, Liang Y, Zhu S, Zhang Y, Chen C, Gao W, Zhang L, Wang J. Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats. Adv Mater. 2018. https://doi.org/10.1002/adma.201704800.10.1002/adma.201704800 ↗
68. Mengze X, Yang Y, Yuan Z. Breast cancer cell membrane camouflaged lipid nanoparticles for tumor-targeted NIR-II phototheranostics. Pharmaceutics. 2022;14(7):1367. https://doi.org/10.3390/pharmaceutics14071367.10.3390/pharmaceutics14071367 ↗
69. Wu Z, Lin X, Si T, He Q. Recent progress on bioinspired self-propelled micro/nanomotors via controlled molecular self-assembly. Small. 2016;12(23):3080–93.10.1002/smll.201503969 ↗
70. Mundaca-Uribe R, Esteban-Fernandez-de-Avila B, Holay M, Lekshmy-Venugopalan P, Nguyen B, Zhou J, Abbas A, Fang RH, Zhang L, Wang J. Zinc Microrocket pills: fabrication and characterization toward active oral delivery. Adv Healthc Mater. 2020;9(18):2000900.10.1002/adhm.202000900 ↗
71. Guix M, Mayorga-Martinez CC, Merkoci A. Nano/micromotors in (bio)chemical science applications. Chem Rev. 2014;114(12):6285–322.10.1021/cr400273r ↗
72. Xu M, Chen Z, Zheng J, Zhao Q, Yuan Z. Artificial intelligence-aided optical imaging for cancer theranostics. Semin Cancer Biol. 2023;94:62–80.10.1016/j.semcancer.2023.06.003 ↗
73. Liu D, Wang T, Lu Y. Untethered microrobots for active drug delivery: from rational design to clinical settings. Adv Healthc Mater. 2022;11(3):e2102253.10.1002/adhm.202102253 ↗
74. Liu J, Xu M, Yuan Z. Immunoscore guided cold tumors to acquire “temperature” through integrating physicochemical and biological methods. BIO Integration. 2020;7(1):6.
75. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):1–33.10.1186/s12951-018-0392-8 ↗
76. Freitas RA. Pharmacytes: an ideal vehicle for targeted drug delivery. J Nanosci Nanotechnol. 2006;6(9–10):2769–75.10.1166/jnn.2006.413 ↗
77. Martins NR, Angelica A, Chakravarthy K, Svidinenko Y, Boehm FJ, Opris I, Lebedev MA, Swan M, Garan SA, Rosenfeld JV, Human brain/cloud interface. In Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data, Jenny Stanford Publishing: 2021; pp 485–538.
78. Mei Y, Solovev AA, Sanchez S, Schmidt OG. Rolled-up nanotech on polymers: from basic perception to self-propelled catalytic microengines. Chem Soc Rev. 2011;40(5):2109–19.10.1039/c0cs00078g ↗
79. Sanchez S, Soler L, Katuri J. Chemically powered micro- and nanomotors. Angew Chem Int Ed Engl. 2015;54(5):1414–44.10.1002/anie.201406096 ↗
80. Kumari S, Mg S, Mayor S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res. 2010;20(3):256–75.10.1038/cr.2010.19 ↗
81. Frcitas RA. Exploratory design in medical nanotechnology: a mechanical artificial red cell. Artif Cells Blood Substit Biotechnol. 1998;26(4):411–30.10.3109/10731199809117682 ↗
82. Aryal M, Vykhodtseva N, Zhang Y-Z, Park J, McDannold N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model. J Control Release. 2013;169(1–2):103–11.10.1016/j.jconrel.2013.04.007 ↗
83. Zottel A, Videtič Paska A, Jovčevska I. Nanotechnology meets oncology: nanomaterials in brain cancer research, diagnosis and therapy. Materials. 2019;12(10):1588.10.3390/ma12101588 ↗
84. Ruff J, Hüwel S, Kogan MJ, Simon U, Galla H-J. The effects of gold nanoparticles functionalized with ß-amyloid specific peptides on an in vitro model of blood–brain barrier. Nanomed Nanotechnol Biol Med. 2017;13(5):1645–52.10.1016/j.nano.2017.02.013 ↗
85. Betzer O, Shilo M, Opochinsky R, Barnoy E, Motiei M, Okun E, Yadid G, Popovtzer R. The effect of nanoparticle size on the ability to cross the blood–brain barrier: an in vivo study. Nanomedicine. 2017;12(13):1533–46.10.2217/nnm-2017-0022 ↗
86. Huang D, Wang Q, Cao Y, Yang H, Li M, Wu F, Zhang Y, Chen G, Wang Q. Multiscale NIR-II imaging-guided brain-targeted drug delivery using engineered cell membrane nanoformulation for alzheimer’s disease therapy. ACS Nano. 2023;17(5):5033–46.10.1021/acsnano.2c12840 ↗
87. Law LH, Huang J, Xiao P, Liu Y, Chen Z, Lai JHC, Han X, Cheng GWY, Tse KH, Chan KWY. Multiple CEST contrast imaging of nose-to-brain drug delivery using iohexol liposomes at 3T MRI. J Control Release. 2023;354:208–20.10.1016/j.jconrel.2023.01.011 ↗
88. Sabry SA, Abd El Razek AM, Nabil M, Khedr SM, El-Nahas HM, Eissa NG. Brain-targeted delivery of Valsartan using solid lipid nanoparticles labeled with Rhodamine B; a promising technique for mitigating the negative effects of stroke. Drug Deliv. 2023;30(1):2179127.10.1080/10717544.2023.2179127 ↗
89. Muresan P, McCrorie P, Smith F, Vasey C, Taresco V, Scurr DJ, Kern S, Smith S, Gershkovich P, Rahman R, Marlow M. Development of nanoparticle loaded microneedles for drug delivery to a brain tumour resection site. Eur J Pharm Biopharm. 2023;182:53–61.10.1016/j.ejpb.2022.11.016 ↗
90. Malinovskaya Y, Melnikov P, Baklaushev V, Gabashvili A, Osipova N, Mantrov S, Ermolenko Y, Maksimenko O, Gorshkova M, Balabanyan V. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int J Pharm. 2017;524(1–2):77–90.10.1016/j.ijpharm.2017.03.049 ↗
91. Li Y, He H, Jia X, Lu W-L, Lou J, Wei Y. A dual-targeting nanocarrier based on poly (amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. Biomaterials. 2012;33(15):3899–908.10.1016/j.biomaterials.2012.02.004 ↗
92. Meng X, Xu Y, Lu Q, Sun L, An X, Zhang J, Chen J, Gao Y, Zhang Y, Ning X. Ultrasound-responsive alkaline nanorobots for the treatment of lactic acidosis-mediated doxorubicin resistance. Nanoscale. 2020;12(25):13801–10.10.1039/D0NR03726E ↗
93. Ishii T, Asai T, Oyama D, Agato Y, Yasuda N, Fukuta T, Shimizu K, Minamino T, Oku N. Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506. FASEB J. 2013;27(4):1362–70.10.1096/fj.12-221325 ↗
94. Picone P, Sabatino MA, Ditta LA, Amato A, San Biagio PL, Mule F, Giacomazza D, Dispenza C, Di Carlo M. Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release. 2018;270:23–36.10.1016/j.jconrel.2017.11.040 ↗
95. Yan L, Wang H, Jiang Y, Liu J, Wang Z, Yang Y, Huang S, Huang Y. Cell-penetrating peptide-modified PLGA nanoparticles for enhanced nose-to-brain macromolecular delivery. Macromol Res. 2013;21:435–41.10.1007/s13233-013-1029-2 ↗
96. Cheng Y, Dai Q, Morshed RA, Fan X, Wegscheid ML, Wainwright DA, Han Y, Zhang L, Auffinger B, Tobias AL. Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging. Small. 2014;10(24):5137–50.10.1002/smll.201400654 ↗
97. Haque S, Md S, Sahni JK, Ali J, Baboota S. Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression. J Psychiatr Res. 2014;48(1):1–12.10.1016/j.jpsychires.2013.10.011 ↗
98. Shao J, Xuan M, Zhang H, Lin X, Wu Z, He Q. Chemotaxis-guided hybrid neutrophil micromotors for targeted drug transport. Angew Chem Int Ed Engl. 2017;56(42):12935–9.10.1002/anie.201706570 ↗
99. Fernandes J, Ghate MV, Mallik SB, Lewis SA. Amino acid conjugated chitosan nanoparticles for the brain targeting of a model dipeptidyl peptidase-4 inhibitor. Int J Pharm. 2018;547(1–2):563–71.10.1016/j.ijpharm.2018.06.031 ↗
100. Taghizadehghalehjoughi A, Hacimuftuoglu A, Cetin M, Ugur AB, Galateanu B, Mezhuev Y, Okkay U, Taspinar N, Taspinar M, Uyanik A. Effect of metformin/irinotecan-loaded poly-lactic-co-glycolic acid nanoparticles on glioblastoma: in vitro and in vivo studies. Nanomedicine. 2018;13(13):1595–606.10.2217/nnm-2017-0386 ↗